Knee Reconstruction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing number of bone-related disorders and the rising product developmental activities across the globe.

The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030. The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative bone conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, thus contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.

Knee Reconstruction/Replacement Devices Market Dynamics:

According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally. Among this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the knee joint, leading to pain, stiffness, and reduced range of motion. This condition often results in significant joint damage that may necessitate knee replacement surgery to restore function and alleviate symptoms.

As per the same source, 13 million people are living with rheumatoid arthritis. This causes the joint lining to become inflamed and eroded, leading to progressive destruction of the cartilage and bone. Knee replacement surgery, either total or partial, is used to replace the damaged joint surfaces with prosthetic components, restoring function and alleviating pain.

Moreover, in October 2023, The Indian Spinal Injuries Centre (ISIC) introduced a new department dedicated to robotic knee replacement surgery, marking a significant advancement in orthopedic care in India. The center deployed the Rosa Robotics Knee System from Zimmer Biomet, based in Warsaw.

Increased product developmental activities such as approvals by the regulatory bodies and launches are also slated to witness the market growth of knee reconstruction/replacement devices. For instance, in June 2024, Meril, a Gujarat-based medical devices company, introduced its indigenously developed surgical robotic technology, MISSO. This innovative system was designed to assist doctors during knee replacement surgeries in real-time and was expected to reduce the cost of these procedures by up to 66 percent.

Hence, the interplay of all the above mentioned factors are expected to drive the market for knee reconstruction/replacement devices during the given forecast period from 2024 to 2030.

However, nerve and blood vessel injury, bleeding, and stiffness associated with implants, nerve damage can cause numbness, weakness and pain and others may restrain the growth of the Knee Reconstruction/Replacement devices market.

Knee Reconstruction/Replacement Devices Market Segment Analysis:

Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the knee reconstruction/replacement devices market, the total knee arthroplasty systems category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due to advanced implants used to treat severe knee arthritis or joint disorders. They consist of three main components-femoral, tibial, and patellar parts, made from durable materials like cobalt-chromium alloys and ultra-high molecular weight polyethylene.

Modern total knee arthroplasty systems feature customizable sizing, modular designs, and advanced technologies such as computer-assisted navigation and robotic assistance to ensure precise implant placement and improved outcomes. These innovations enhance joint function, reduce pain, and accelerate recovery, significantly improving patients' quality of life.

Additionally, the rising product developmental activities increases the market for these. For example, in May 2024, OrthAlign, Inc., a leading innovator in surgical technology, announced the launch of its flagship product, Lantern, in Japan for total knee arthroplasty. The launch was supported by its longstanding commercial partner, who had represented OrthAlign in the market since 2013 and had supported over 68,000 OrthAlign cases.

Therefore, the presence of a robust product portfolio for the total knee arthroplasty systems category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall knee reconstruction/replacement devices market:

Among all the regions, North America is expected to amass the largest share of the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.

According data from the American Academy of Orthopaedic Surgeons in 2024 stated that over 700,000 total knee replacement surgeries are performed each year in the US. In addition to this, recent updates provided by the Arthritis Society Canada (2022), stated that 1 million Canadians were affected by gout, which is the most common form of inflammatory arthritis. Gout predominantly impacts males more than females, with approximately 4% of men and 1% of women affected. Among the various joints that can be affected, the knee joint is the most commonly involved. Knee replacement and reconstruction surgeries are crucial for managing severe knee pain and dysfunction caused by conditions like arthritis and gout. These procedures are especially important for patients whose knee joints are significantly affected, offering relief from pain and improved mobility by replacing damaged joints with artificial ones.

The product developmental activities by regulatory bodies in the region also push forward the revenue shares of knee reconstruction devices. For example in July 2024, Globus Medical, Inc. announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) application. This new robotic navigation platform was added to the already best-in-class Excelsius™ ecosystem, designed to provide surgeons with enhanced control, resection accuracy, and procedural flexibility in Total Knee Arthroplasty. Additionally, the ACTIFY™ 3D Total Knee System, the latest in implant technology designed to pair with ExcelsiusFlex™, also received 510(k) clearance.

Moreover, the presence of key players such as Zimmer Biomet, Stryker, Johnson & Johnson Services, Inc, Exactech, Inc., and others in the region is also a driving factor for the knee reconstruction/replacement devices market as they hold significant revenue shares.

Thus, all the factors mentioned above promote a conducive environment for the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.

Knee Reconstruction/Replacement Devices Market key players:

Some of the key market players operating in the Knee Reconstruction/Replacement Devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.

Recent Developmental Activities in the Knee Reconstruction/Replacement Devices Market:

• In August 2021, Fuse Medical, Inc. announced FDA 510(k) Clearance of the Sterizo™ Tibial Revision Knee System and PS plus Posterior Stabilized Tibial Insert.

Key Takeaways from the Knee Reconstruction/Replacement Devices Market Report Study

• Market size analysis for current knee reconstruction/replacement devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the knee reconstruction/replacement devices market
• Various opportunities available for the other competitors in the knee reconstruction/replacement devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current knee reconstruction/replacement devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for knee reconstruction/replacement devices market growth in the coming future?

Target audience who can be benefited from this Knee Reconstruction/Replacement Devices Market Report Study

• Knee reconstruction/replacement device providers
• Research organizations and consulting companies
• Knee reconstruction/replacement devices related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in knee reconstruction/replacement devices
• Various end-users who want to know more about the knee reconstruction/replacement devices market and the latest developments in the knee reconstruction/replacement devices market

Frequently Asked Questions for the Knee Reconstruction/Replacement Devices Market:

1. What is Knee Reconstruction/Replacement Devices?

The knee reconstruction/replacement devices are devices designed to replace cartilage and bone which is damaged from musculoskeletal disease or aging. There are various replacement devices such as total knee arthroplasty systems, and partial knee arthroplasty systems, among others.

2. What is the market for Knee Reconstruction/Replacement Devices?

The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030.

3. What are the drivers for the Knee Reconstruction/Replacement Devices market?

The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Knee Reconstruction/Replacement Devices market?

Some of the key market players operating in the Knee Reconstruction/Replacement devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc., Johnson & Johnson Services, Inc., Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.

5. Which region has the highest share in the Knee Reconstruction/Replacement Devices market?

Among all the regions, North America is estimated to hold a significant revenue share in the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.